AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

QUETIAPINE 300 Mg ;

12 registrations across 1 African market— 12 active

Markets with QUETIAPINE 300 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Quetiapine 300 mg
Film Coated Tablets
🇪🇬EgyptFUTURE PHARMACEUTICAL INDUSTRIES-EGYPTactive
Psyquel XR 300 mg
Extended Release Film Coated Tablets
🇪🇬EgyptChemipharm Pharmaceutical Industriesactive
Spiraquet
Extended Release Film Coated Tablets
🇪🇬EgyptMedizen pharmaceutical industries (Medizen)active
Quedress 300mg
Film Coated Tablets
🇪🇬EgyptPharmacredoactive
Quitafare 300 mg
Film Coated Tablets
🇪🇬EgyptThe Arab drug company for pharmaceuticals and chemical industriesactive
Prexoquit
Extended Release Film Coated Tablets
🇪🇬EgyptMash for pharmaceutical Industries and cosmetic - mash premiereactive
Psyquel XR 300 mg
Extended Release Film Coated Tablets
🇪🇬EgyptChemipharm Pharmaceutical Industriesactive
Quetiapine 300 mg
Film Coated Tablets
🇪🇬EgyptFUTURE PHARMACEUTICAL INDUSTRIES-EGYPTactive
Spiraquet
Extended Release Film Coated Tablets
🇪🇬EgyptMedizen pharmaceutical industries (Medizen)active
Quitafare 300 mg
Film Coated Tablets
🇪🇬EgyptThe Arab drug company for pharmaceuticals and chemical industriesactive
Prexoquit
Extended Release Film Coated Tablets
🇪🇬EgyptMash for pharmaceutical Industries and cosmetic - mash premiereactive
Quedress 300mg
Film Coated Tablets
🇪🇬EgyptPharmacredoactive

QUETIAPINE 300 Mg ; in Africa — Regulatory Overview

QUETIAPINE 300 Mg ; is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.